Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist


379.300 DKK 7.200 1.86%

As of 11:04:33 ET on 05/29/2015.

Snapshot for Novo Nordisk A/S (NOVOB)

Open: 389.800 Day's Range: 379.300 - 390.200 Volume: 10,197,632
Previous Close: 386.500 52wk Range: 230.800 - 400.200 1-Yr Rtn: +66.02%

Stock Chart for NOVOB

No chart data available.
  • NOVOB:DC 379.300
  • 1D
  • 1M
  • 1Y
Interactive NOVOB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOVOB

Current P/E Ratio (ttm) 33.0936
Estimated P/E(12/2015) 29.5658
Relative P/E vs. KFX 1.2366
Earnings Per Share (DKK) (ttm) 11.4614
Est. EPS (DKK) (12/2015) 12.8290
Est. PEG Ratio 1.9563
Market Cap (M DKK) 986,179.99
Shares Outstanding (M) 2,062.56
30 Day Average Volume 3,204,619
Price/Book (mrq) 31.3051
Price/Sale (ttm) 10.5653
Dividend Indicated Gross Yield 1.32%
Cash Dividend (DKK) 5.0000
Dividend Ex-Date 03/20/2015
5 Year Dividend Growth 27.23%
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOVOB

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NOVOB

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Lars Rebien SorensenPresident/CEOJesper BrandgaardChief Financial Officer
Lars Fruergaard JorgensenExec VP:Corp DevelopmentJakob RiisExec VP: Marketing,Medic Affers&Stakehold ENG
More Company Profile & Key Executives for NOVOB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil